Articles related to GUIDELINES/RECOMMENDATIONS

The Endocrine Society’s 2024 guidelines suggest against routine vitamin D screening and supplementation for most adults under 75, marking a significant shift in clinical practice recommendations.

The FDA’s new mandate requires all mammography facilities to inform women about their breast density, recognizing its significance in cancer risk and detection challenges.

The PREVENT equation, developed by the American Heart Association in 2023, aims to provide a more accurate cardiovascular risk assessment for today’s population, potentially reducing statin prescriptions by 40%.

The CDC reports “very high” COVID-19 levels in 32 states, with two new Omicron variants accounting for more than half of all US cases.

Changes to blood-based biomarkers can be detected before Alzheimer’s symptoms appear, potentially allowing for earlier intervention and more targeted treatment approaches.

The 2024 U.S. SPR emphasizes the paramount importance of personal autonomy in contraceptive decision-making, particularly in light of historical and ongoing contraceptive coercion and reproductive mistreatment in the United States.